Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series

BACKGROUND: Mycobacterium abscessus (M. abscessus) pulmonary disease is a refractory chronic infectious disease. Options for treating M. abscessus pulmonary disease are limited, especially in outpatient settings. Among parenteral antibiotics against M. abscessus, intravenous amikacin (AMK) is expect...

Descripción completa

Detalles Bibliográficos
Autores principales: Namkoong, Ho, Morimoto, Kozo, Nishimura, Tomoyasu, Tanaka, Hiromu, Sugiura, Hiroaki, Yamada, Yoshitake, Kurosaki, Atsuko, Asakura, Takanori, Suzuki, Shoji, Fujiwara, Hiroshi, Yagi, Kazuma, Ishii, Makoto, Tasaka, Sadatomo, Betsuyaku, Tomoko, Hoshino, Yoshihiko, Kurashima, Atsuyuki, Hasegawa, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977760/
https://www.ncbi.nlm.nih.gov/pubmed/27506679
http://dx.doi.org/10.1186/s12879-016-1689-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977760/
https://www.ncbi.nlm.nih.gov/pubmed/27506679
http://dx.doi.org/10.1186/s12879-016-1689-6

Ejemplares similares